ZYME - Zymeworks Announces Participation in Upcoming Investor Conferences | Benzinga

VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences:

• Jefferies London Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on November 14^th at 11:30 am Greenwich Mean Time in London, UK.
• Stifel 2023 Healthcare Conference: Zymeworks' management will participate in one-on-one meetings and a fireside chat on November 14^th at 1:15pm Eastern Time (ET) in New York, NY.
• 6^th Annual Evercore ISI HealthCONx Conference: Zymeworks' management will participate in one-on-one meetings and fireside chat on November 28^th at 2:10 pm ET in Miami, FL.
  

All presentations and webcasts will be ...

Full story available on Benzinga.com